Back to top

Image: Shutterstock

Zacks.com featured highlights include Las Vegas Sands, Voyager Therapeutics and nCino

Read MoreHide Full Article

For Immediate Release

Chicago, IL – February 13, 2023 – Stocks in this week’s article are Las Vegas Sands (LVS - Free Report) , Voyager Therapeutics (VYGR - Free Report) and nCino (NCNO - Free Report) .

3 Best Stocks to Invest In for Remarkable Earnings Acceleration

We all know that constant earnings growth captivates almost everyone, from the top brass to research analysts. This is because earnings are a measure of the money a company is making. Still, earnings acceleration works even better when it comes to lifting the stock price. Studies have shown that most successful stocks had seen an acceleration in earnings before an uptick in the stock price.

Earnings acceleration is the incremental growth in a company's earnings per share (EPS). In other words, if the rate of a company's quarter-over-quarter earnings growth increases within a stipulated frame of time, it can be called earnings acceleration.

In case of earnings growth, you pay for something that is already reflected in the stock price. But earnings acceleration helps spot stocks that haven't yet caught the attention of investors and, once secured, will invariably lead to a rally in the share price. This is because earnings acceleration considers both the direction and magnitude of growth rates.

An increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period. Meanwhile, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may at times drag prices down.

The above criteria narrowed down the universe of around 7,735 stocks to only four. Here are the top three stocks:

Las Vegas Sands is a leading international developer of multi-use integrated resorts primarily operating in the U.S. and Asia. Las Vegas Sands currently has a Zacks Rank #1 (Strong Buy). LVS' expected earnings growth rate for the current year is 217.5%. You can see the complete list of today's Zacks #1 Rank stocks here.

Voyager Therapeutics is a gene therapy company. Voyager Therapeutics currently has a Zacks Rank #2 (Buy). The expected earnings growth rate for VYGR for the current year is 38.1%.

nCino is a provider of cloud-based software for financial institutions. nCino currently has a Zacks Rank #2. The company's expected earnings growth rate for the current year is 20%.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2052721/3-best-stocks-to-invest-in-for-remarkable-earnings-acceleration

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://www.twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Las Vegas Sands Corp. (LVS) - free report >>

Voyager Therapeutics, Inc. (VYGR) - free report >>

nCino Inc. (NCNO) - free report >>

Published in